Revista Cubana de Salud Pública
Print version ISSN 0864-3466
ACOSTA MARTINEZ, Maylén et al. Improved access to clinical assay information. Rev. cub. salud pública [online]. 2010, vol.36, n.3, pp. 285-288. ISSN 0864-3466. http://dx.doi.org/10.1590/S0864-34662010000300019.
The Molecular Immunology Center has been developing biomolecules for cancer treatment. As the development of such products continues, phases I, II, III and IV of clinical assays also advance, which leads to an increase of the number of patients to be treated and the number of involved hospitals. There are ten different products involved in over 50 national and multinational clinical assays in which 2 500 patients are predicted to be included every year. Approximately 30 hospitals from 13 provinces are included in this process. For the purpose of improving the access of committed researchers to the clinical assay information, a new Website with four sections was devised. Those sections are related to products and their indications, good clinical practice, remote data entry and clinical assay management. All the above-mentioned improves the quality of the information given to involved clinical researchers and results in better organization of the complex activity of clinical assays in Cuba.
Keywords : Website; remote data entry; good clinical practice; management; clinical assays.